Masafumi Nakayama’s research while affiliated with Tohoku University and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (48)


Author Correction: IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
  • Article
  • Full-text available

December 2024

·

18 Reads

·

Masafumi Nakayama

·

·

[...]

·

Mark J. Smyth
Download

MHC class I-dressing is mediated via phosphatidylserine recognition and is enhanced by polyI:C

April 2024

·

10 Reads

iScience

In addition to cross-presentation, cross-dressing plays an important role in the induction of CD8⁺ T cell immunity. In the process of cross-dressing, conventional dendritic cells (DCs) acquire major histocompatibility complex class I (MHCI) from other cells and subsequently prime CD8⁺ T cells via the pre-formed antigen-MHCI complexes without antigen processing. However, the mechanisms underlying the cross-dressing pathway, as well as the relative contributions of cross-presentation and cross-dressing to CD8⁺ T cell priming are not fully understood. Here, we demonstrate that DCs rapidly acquire MHCI-containing membrane fragments from dead cells via the phosphatidylserine recognition-dependent mechanism for cross-dressing. The MHCI dressing is enhanced by a TLR3 ligand polyinosinic-polycytidylic acid (polyI:C). Further, polyI:C promotes not only cross-presentation but also cross-dressing in vivo. Taken together, these results suggest that cross-dressing as well as cross-presentation is involved in inflammatory diseases associated with cell death and type I IFN production.


Identification of Siglec-5 as a CNT-recognizing receptor
a, Strategy for in silico screening of macrophage receptors harbouring clusters of aromatic residues. b, Three-dimensional structures of Siglec-5, Siglec-3 and Tim4. Arrowheads indicate aromatic residues: WY50/51 (Siglec-5), YY49/50 (Siglec-3) and WF119/120 (Tim4). c, Parental NIH-3T3 cells and NIH-3T3 cells stably expressing Siglec-5, Siglec-3 or Tim4 were cultured with 10 or 30 μg ml⁻¹ of MWCNTs for 30 min and binding was analysed by flow cytometry. The delta median side scatter intensity (∆MSI) was calculated by subtracting the MSI of MWCNT-treated cells from the MSI of untreated cells. See also Extended Data Fig. 1. Data are shown as mean ± s.d. (n = 3). ***P < 0.001, two-way ANOVA with Tukey–Kramer test.
Source data
MD simulations and in vitro validation to clarify the binding modes of Siglec-5 to MWCNTs
a, Snapshots from the simulation trajectories in modes 1, 2 and 4 are shown. See also Supplementary Fig. 4 for modes 3 (unbound form) and 5. b, The architecture of the CNT interaction interface of Siglec-5 is schematically presented. The simulation model for Siglec-5 consists of extracellular domains that are indicated by open and filled cylinders. The four interaction interfaces at the bottom of the V-set Ig-like domain are marked with pink triangles. c, Relative populations of each binding mode in simulation ensembles of WT (left), WY50/51AA (centre) and WYYY50/51/68/69AAAA (right) are shown as pie charts. d, Diverse tilt angle of Siglec-5 over the CNT surface was observed in simulation trajectories of WT (black), WY50/51AA (red) and WYYY50/51/68/69AAAA (cyan) models. The tilt angle is defined as the C–B–A angle, as shown on the left. See also Methods. The standard deviations of the angles of WT, WY50/51AA and WYYY50/51/68/69AAAA were 8.95°, 15.8° and 16.3°, respectively. e, The recognition of MWCNTs by the indicated NIH-3T3 cells was analysed as in Fig. 1c. See also Supplementary Fig. 6. Data are shown as mean ± s.d. (n = 3). **P = 0.0023, ***P < 0.001, two-way ANOVA with Tukey–Kramer test.
Source data
Siglec-14, but not Siglec-5, engulfs MWCNTs to induce IL-1β secretion and pulmonary inflammation
a, Siglec expression in cells treated with MWCNTs for 24 h was analysed by immunoblot. See also Methods. b,c, Siglec expression on MWCNT-treated cells was analysed by flow cytometry at 5 h (b) and at the indicated time points (c). Red and black lines indicate SY2 and control mouse IgG1 (cIg) staining, respectively (b). The percentage reduction of Siglec expression on cells was calculated as the MSI of Siglec staining on MWCNT-treated cells at the indicated time point × 100/MSI of Siglec staining on untreated cells (c). d, Cell recognition of MWCNTs was analysed as in Fig. 1c. Data are shown as mean ± s.d. (n = 3). ***P < 0.001, two-way ANOVA with Tukey–Kramer test. e, MWCNT-treated cells were stained with AF488-phalloidin and 4,6-diamidino-2-phenylindole and were then analysed by fluorescence microcopy. f, Caspase-1 activation was analysed by immunoblot. See also Methods. g, IL-1β secretion was analysed by ELISA. Data are shown as mean ± s.d. (n = 3). ***P < 0.001, two-way ANOVA with Tukey–Kramer test. h, B6 mice (n = 4) were intratracheally infected with mock or Siglec-14 lentivirus (lenti). Siglec-14 expression on Siglec-F⁺ alveolar macrophages was analysed in BALF cells by flow cytometry. Representative data are shown. See also Supplementary Fig. 11a. i, Siglec-14-transduced mice (n = 4) were intratracheally injected with a single dose of MWCNTs (50 μg per head). After 1 day, BALF cells were harvested. MWCNT recognition by Siglec-F⁺ Siglec-14⁻ or Siglec-F⁺ Siglec-14⁺ alveolar macrophages was analysed as in Fig. 1c. See also Supplementary Fig. 11b. ***P < 0.001, unpaired two-tailed t-test. j, Mock- or Siglec-14-transduced mice (n = 4 each) were treated as in i. IL-1β was quantified in BALF by ELISA. Data are shown as mean ± s.d. (n = 3). *P = 0.0228, ***P < 0.001, two-way ANOVA with Tukey–Kramer test. k, Mock- or Siglec-14-transduced mice (n = 3 each) were treated as in i. Lungs were analysed by haematoxylin and eosin staining. Representative data are shown. Boxed areas in Supplementary Fig. 11c show higher magnification.
Source data
Siglec-14-mediated recognition of MWCNTs by human monocytes
a, Human pulmonary fibrosis tissue was stained with anti-CD68 and SY2, followed by AF568-anti-rabbit IgGs and AF488-anti-mouse IgGs, respectively. b, Siglec-5/14 expression on PBMCs from healthy human donors was analysed as in Fig. 3b. c, Schematic illustration of Siglec14 gene structure and primers for the genotyping PCR. d, Genomic DNA was prepared from PBMCs and the Siglec14 (S14) genotype was determined by standard PCR using a primer pair shown in c. e, PBMCs pretreated with cIg or SY2 (10 μg ml⁻¹ each) were treated with MWCNTs (30 μg ml⁻¹) for 30 min. Then cells were stained with anti-CD14 mAb. Numbers indicate MSI. f, PBMCs were treated as in e. MWCNT recognition by CD14⁺ PB monocytes or CD14⁻ PB lymphocytes was calculated as in Fig. 1c. Data are shown as mean ± s.d. (n = 3). ***P < 0.001, two-way ANOVA with Tukey–Kramer test. g, LPS (1 ng ml⁻¹)-primed PBMCs were pretreated with mAb (10 μg ml⁻¹) and were then treated with MWCNTs or ATP for 3 h. IL-1β secretion was analysed by ELISA. Data are shown as mean ± s.d. (n = 3). *P = 0.0306, **P = 0.0043, ***P < 0.001, two-way ANOVA with Tukey–Kramer test.
Source data
Siglec-14-Syk-mediated inflammatory responses to MWCNTs are blocked by fostamatinib
a, Syk null cells were generated by CRISPR/Cas9-mediated targeting and were cloned by limiting dilution. Syk expression was analysed by immunoblot. b, Sequence of Syk in WT cells and mutant clone #3 alleles around the target locus. The gRNA target sequence is in bold. Deleted bases are indicated by hyphens. c, Cell surface expression of Siglec-14 on the indicated THP-1 cells was analysed as in Fig. 3b. d, Phagocytosis of MWCNTs by the indicated THP-1 cells was analysed as in Fig. 3e. e, IL-1β secretion from the indicated THP-1 cells was analysed as in Fig. 3g. Data are shown as mean ± s.d. (n = 3). ***P < 0.001, one-way ANOVA with Tukey–Kramer test. f, PMA-primed Siglec-14/THP-1 cells were pretreated with the indicated dose of R406 for 1 h and then were treated with MWCNTs (30 μg ml⁻¹) or nigericin (3 μM) for 5 h. The percentage reduction of IL-1β secretion was calculated as the amount of IL-1β produced by the indicated dose of R406-treated cells × 100/the amount of IL-1β produced by R406-untreated cells. Data are shown as mean ± s.d. (n = 3). **P = 0.0042, ***P < 0.001, one-way ANOVA with Tukey–Kramer test. g, LPS-primed S14+/− donor PBMCs (n = 4) were pretreated the indicated dose of R406 for 1 h and then were treated with MWCNTs (10 μg ml⁻¹) or ATP (1 mM) for 3 h. The percentage reduction of IL-1β secretion in individuals was calculated as in f. Data are shown as mean ± s.d. (n = 4). ***P < 0.01, one-way ANOVA with Tukey–Kramer test. h, Mock- or Siglec-14-transduced mice (n = 6 each) generated as in Fig. 3h were orally administered with R788 (0.6 mg per head) or vehicle (0.5% w/v methyl cellulose 400 solution) at 12 h and 0.5 h before intratracheal injection of MWCNTs (50 μg per head). One day later, the concentration of IL-1β and TNF-α in BALF was measured by ELISA. *P = 0.0267, ***P < 0.001, two-way ANOVA with Tukey–Kramer test.
Source data
Carbon nanotube recognition by human Siglec-14 provokes inflammation

April 2023

·

159 Reads

·

19 Citations

Nature Nanotechnology

For the design and development of innovative carbon nanotube (CNT)-based tools and applications, an understanding of the molecular interactions between CNTs and biological systems is essential. In this study, a three-dimensional protein-structure-based in silico screen identified the paired immune receptors, sialic acid immunoglobulin-like binding lectin-5 (Siglec-5) and Siglec-14, as CNT-recognizing receptors. Molecular dynamics simulations showed the spatiotemporally stable association of aromatic residues on the extracellular loop of Siglec-5 with CNTs. Siglec-14 mediated spleen tyrosine kinase (Syk)-dependent phagocytosis of multiwalled CNTs and the subsequent secretion of interleukin-1β from human monocytes. Ectopic in vivo expression of human Siglec-14 on mouse alveolar macrophages resulted in enhanced recognition of multiwalled CNTs and exacerbated pulmonary inflammation. Furthermore, fostamatinib, a Syk inhibitor, blocked Siglec-14-mediated proinflammatory responses. These results indicate that Siglec-14 is a human activating receptor recognizing CNTs and that blockade of Siglec-14 and the Syk pathway may overcome CNT-induced inflammation.


Tim4, a macrophage receptor for apoptotic cells, binds polystyrene microplastics via aromatic-aromatic interactions

March 2023

·

67 Reads

·

10 Citations

The Science of The Total Environment

Understanding the interface between microplastics and biological systems will provide new insights into the impacts of microplastics on living organisms. When microplastics enter the body, they are engulfed preferentially by phagocytes such as macrophages. However, it is not fully understood how phagocytes recognize microplastics and how microplastics impact phagocyte functions. In this study, we demonstrate that T cell immunoglobulin mucin 4 (Tim4), a macrophage receptor for phosphatidylserine (PtdSer) on apoptotic cells, binds polystyrene (PS) microparticles as well as multi-walled carbon nanotubes (MWCNTs) through the extracellular aromatic cluster, revealing a novel interface between microplastics and biological systems via aromatic-aromatic interactions. Genetic deletion of Tim4 demonstrated that Tim4 is involved in macrophage engulfment of PS microplastics as well as of MWCNTs. While Tim4-mediated engulfment of MWCNTs causes NLRP3-dependent IL-1β secretion, that of PS microparticles does not. PS microparticles neither induce TNF-α, reactive oxygen species, nor nitric oxide production. These data indicate that PS microparticles are not inflammatory. The PtdSer-binding site of Tim4 contains an aromatic cluster that binds PS, and Tim4-mediated macrophage engulfment of apoptotic cells, a process called efferocytosis, was competitively blocked by PS microparticles. These data suggest that PS microplastics do not directly cause acute inflammation but perturb efferocytosis, raising concerns that chronic exposure to large amounts of PS microplastics may cause chronic inflammation leading to autoimmune diseases.


Figure 2. Trogocytosis in T cell priming and effector phases. During the priming phase, dendritic cell (DC) type 2 cells (DC2s) present extracellular tumor antigens on MHCII to activate CD4 + T cells whereas DC type 1 cells (DC1s) are able to present them on MHCI, called cross-presentation, to activate CD8 + T cells. In addition, DC1s and/or DC2s acquire preformed antigen-MHCI complexes for antigen presentation to CD8 + T cells, which is called cross-dressing. In the cytotoxic T lymphocyte (CTL) effector phase, CTLs strip off target antigens from tumor cells. These CTLs with acquired tumor antigen-MHCI are then lysed by tumor-unexperienced CTLs through a process called fratricide cell death. On the other hand, tumor cells lose antigens, resulting in generation of CTL escape variants.
Figure 3. Trogocytosis in allograft transplantation. Alloreactive T cell activation is induced by three pathways. The first is the direct pathway where intact MHC alloantigens on donor DCs are recognized by recipient T cells, promoting acute rejection. The second is the indirect pathway where allograft antigens are internalized and processed by recipient DCs, on which donor antigen-recipient MHC complexes are recognized by recipient T cells, promoting chronic rejection. The third pathway is a semi-direct pathway of so-called cross-dressing where recipient DCs acquire preformed donor antigen-MHC complexes and are recognized by recipient T cells.
Figure 4. Trogocytosis in Treg-mediated immune suppression. Treg cells strip off MHCII and costimulatory molecules from DCs and as a result these DCs have an impaired antigen-presenting activity.
Shaping of T Cell Functions by Trogocytosis

May 2021

·

682 Reads

·

25 Citations

Cells

Trogocytosis is an active process whereby plasma membrane proteins are transferred from one cell to the other cell in a cell-cell contact-dependent manner. Since the discovery of the intercellular transfer of major histocompatibility complex (MHC) molecules in the 1970s, trogocytosis of MHC molecules between various immune cells has been frequently observed. For instance, antigen-presenting cells (APCs) acquire MHC class I (MHCI) from allografts, tumors, and virally infected cells, and these APCs are subsequently able to prime CD8+ T cells without antigen processing via the preformed antigen-MHCI complexes, in a process called cross-dressing. T cells also acquire MHC molecules from APCs or other target cells via the immunological synapse formed at the cell-cell contact area, and this phenomenon impacts T cell activation. Compared with naïve and effector T cells, T regulatory cells have increased trogocytosis activity in order to remove MHC class II and costimulatory molecules from APCs, resulting in the induction of tolerance. Accumulating evidence suggests that trogocytosis shapes T cell functions in cancer, transplantation, and during microbial infections. In this review, we focus on T cell trogocytosis and the related inflammatory diseases.


Figure 3. Molecular dynamics simulations of the interaction between Tim4 mutants and CNT (A) Snapshots of the interaction between Tim4 mutant IgV domains and CNT are shown at the indicated simulation time points. Tim4 mutants are shown in the same way as in Figure 2B. See also Videos S2, S3, S4, and S5. (B) Root-mean-square fluctuation (RMSF) of the Ca atom of WT Tim4, and the indicated mutant was calculated over the MD trajectories. L1-L8 are the large loops in Tim4 shown in Figure 2B. See also Figure S2. (C) Schematic diagram of the tilt angle, which is defined as the angle between the x-y plane and the vector connecting Ca atoms of W119 and G105. (D) Distribution of the tilt angle defined as in (C) is shown over 100 ns MD trajectories. (E) Schematic diagram of the area of interface between Tim4 and CNT. (F) Distribution of the interface area defined as in (E) is shown over 95 ns MD trajectories. See also Figure S4.
Tim4 recognizes carbon nanotubes and mediates phagocytosis leading to granuloma formation

February 2021

·

73 Reads

·

29 Citations

Cell Reports

Macrophage recognition and phagocytosis of crystals is critical for the associated fibrosis and cancer. Of note, multi-walled carbon nanotubes (MWCNTs), the highly representative products of nanotechnology, induce macrophage NLRP3 inflammasome activation and cause asbestosis-like pathogenesis. However, it remains largely unknown how macrophages efficiently recognize MWCNTs on their cell surfaces. Here, we identify by a targeted screening of phagocyte receptors the phosphatidylserine receptors T cell immunoglobulin mucin 4 (Tim4) and Tim1 as the pattern-recognition receptors for carbon crystals. Docking simulation studies reveal spatiotemporally stable interfaces between aromatic residues in the extracellular IgV domain of Tim4 and one-dimensional carbon crystals. Further, CRISPR-Cas9-mediated deletion of Tim4 and Tim1 reveals that Tim4, but not Tim1, critically contributes to the recognition of MWCNTs by peritoneal macrophages and to granuloma development in a mouse model of direct mesothelium exposure to MWCNTs. These results suggest that Tim4 recognizes MWCNTs through aromatic interactions and mediates phagocytosis leading to granulomas.



Particle-induced NLRP3 inflammasome activation and cell death. Signal 1 induces pro-IL-1β along with NLRP3 through the nuclear factor-kappa B (NF-κB) pathway. Signal 2 causes lysosomal damages and stimulates the assembly of a complex of multiple proteins including NLRP3, ASC, and procaspase-1, resulting in the formation of inflammasomes. Active caspase-1 processes pro-IL-1β and pro-gasdermin D to mature IL-1β and gasdermin D. Lysosomal damage results in the release of the lysosomal enzyme cathepsins, which may induce NLRP3 inflammasome-independent pyroptotic cell death. Receptor-interacting serine/threonine kinase-mixed-lineage kinase domain-like protein (RIPK3-MLKL) pathway is involved in crystal-induced necroptosis in epithelial cells but not in macrophages.
The recognition of crystals and nanoparticles on the macrophage surface. Macrophages recognize and internalize crystals and nanoparticles through cell-surface receptors and membrane cholesterol. Silica particles are recognized by SR-A1, MARCO, SR-B1, and CD36. Alum, poly(methyl methacrylate) (PMMA), and monosodium urate (MSU) crystals bind directly to membrane cholesterol to be internalized. MSU and cholesterol crystals activate complement pathways. Soluble oxidized low-density lipoprotein (oxLDL) is internalized by CD36 and then crystallized in phagosomes. P2X7R does not cause lysosomal damage. In addition to these, many unknown pathways of phagocytosis remain to be identified.
Macrophage Recognition of Crystals and Nanoparticles

January 2018

·

378 Reads

·

142 Citations

Inhalation of exogenous crystals such as silica, asbestos, and carbon nanotubes can cause lung fibrosis and cancer. Endogenous crystals such as monosodium urate, cholesterol, and hydroxyapatite are associated with pathogenesis of gout, atherosclerosis, and osteoarthritis, respectively. These crystal-associated-inflammatory diseases are triggered by the macrophage NLRP3 inflammasome activation and cell death. Therefore, it is important to understand how macrophages recognize crystals. However, it is unlikely that macrophages have evolutionally acquired receptors specific for crystals or recently emerged nanoparticles. Several recent studies have reported that some crystal particles are negatively charged and are recognized by scavenger receptor family members in a charge-dependent manner. Alternatively, a model for receptor-independent phagocytosis of crystals has also been proposed. This review focuses on the mechanisms by which macrophages recognize crystals and nanoparticles.


Figure 1. Characteristics and structure of the polymers prepared. (A) Table of characteristics for RhoPs. All RhoP polymers contain 10 mol% PEGMA. (B) Schematic representation of RhoPs. (C) Chemical structure of αRhoP and ωRhoP. 
Figure 2. (A) Viability of HeLa cells treated with RhoPs (1.0 mg/mL). After addition of each polymer, cells were incubated at 37 °C, 5% CO 2 for 24 h. The number of cells was evaluated by the Trypan blue assay. (n = 4) (B) Relative mitochondrial activity of HeLa cells 24 h upon RhoPs addition. The mitochondrial activity was evaluated by the MTT assay. (n = 4) The red column in each bar of the graph indicates the position of Rho on the polymer. Left: αRhoP, Middle: sRhoP, Right: ωRhoP. 
Figure 3. (A) Micrographs of HeLa cells at various times post treatment with αRhoP-18k. αRhoP-18k (1.0 mg/ mL) was added in the presence of serum. Micrographs were recorded from 0 to 5 min. (B) Colocalization of αRhoP (Red) and MitoTracker ® (Green) in HeLa cells. After 1 h treatment of αRhoP-18k (upper) and αRhoH30k (lower) in the presence of serum, MitoTracker was added to the cells. (C) Super resolution fluorescence micrograph of αRhoP-18k added to HeLa cell. The white dotted line outlines a mitochondrion. The inset gives a schematic representation of the part of the cell observed. 
Figure 4. Fluorescence intensity of RhoP-treated HeLa cells. Each polymer was added to HeLa cells and incubated for 1 h. The fluorescent intensity was evaluated by flow cytometry and analyzed for 5,000 cells. For the analysis, the fluorescence intensity values were normalized based on the Rho substitution degree of each polymer. [RhoP] = 1.0 mg/mL (A) Effect of the PEG chain length. The substitution degree of PEGMA was approximately the same in all polymers; the molecular weight of PEGMA was 2,000 g/mol (left) and 500 g/mol (right). (B) Effect of the position of Rho. The statistical significance of the difference is indicated by * (p < 0.01) vs sRhoP. (C) Effect of molecular weight of αRhoPs. (inset) Data plotted as a function of the polymer molar concentration.
Figure 5. Effect of endocytosis inhibitors on the uptake of RhoPs by HeLa cells. The fluorescence intensity of HeLa cells was evaluated by flow cytometry. The 100% of Mean F.I. are the values of each RhoP in the absence of inhibitor incubated at 37 °C for 1 h. α: αRhoP-18k, ω: ωRhoP-21k, s: sRhoP-18k and h: αRhoH-30k. Cytochalasin D: 10 µM, Sucrose: 0.45 M, MβCD: 10 mM, Nystatin 27 µM. 
Fast and effective mitochondrial delivery of ω-Rhodamine-B-polysulfobetaine-PEG copolymers

January 2018

·

207 Reads

·

18 Citations

Mitochondrial targeting and entry, two crucial steps in fighting severe diseases resulting from mitochondria dysfunction, pose important challenges in current nanomedicine. Cell-penetrating peptides or targeting groups, such as Rhodamine-B (Rho), are known to localize in mitochondria, but little is known on how to enhance their effectiveness through structural properties of polymeric carriers. To address this issue, we prepared 8 copolymers of 3-dimethyl(methacryloyloxyethyl)ammonium propane sulfonate and poly(ethyleneglycol) methacrylate, p(DMAPS-ran-PEGMA) (molecular weight, 18.0 < M n < 74.0 kg/mol) with two different endgroups. We labeled them with Rho groups attached along the chain or on one of the two endgroups (α or ω). From studies by flow cytometry and confocal fluorescence microscopy of the copolymers internalization in HeLa cells in the absence and presence of pharmacological inhibitors, we established that the polymers cross the cell membrane foremost by translocation and also by endocytosis, primarily clathrin-dependent endocytosis. The most effective mitochondrial entry was achieved by copolymers of M n < 30.0 kg/mol, lightly grafted with PEG chains (< 5 mol %) labeled with Rho in the ω-position. Our findings may be generalized to the uptake and mitochondrial targeting of prodrugs and imaging agents with a similar polymeric scaffold.



Citations (40)


... cNt exposure can cause oxidative stress via overproduction of ROS in cells, leading to cytotoxicity [81,[91][92][93]. they can activate inflammatory pathways, triggering the release of pro-inflammatory cytokines and chemokines [94][95][96][97]. they can directly damage DNA or indirectly induce DNA damage (genotoxicity) through ROS production, potentially leading to mutations and cancer development [98,99]. ...

Reference:

Therapeutic and diagnostic applications of carbon nanotubes in cancer: Recent advances and challenges
Carbon nanotube recognition by human Siglec-14 provokes inflammation

Nature Nanotechnology

... If MPs accumulate in this compartment, it may disrupt the normal route for absorbing endogenous microparticles, which can mess with the immune system's ability to detect and fight off foreign substances, ultimately weakening local immunity (Wright and Kelly, 2017). In the small intestine epithelium, macrophages bind to MPs/NPs with their Tim4 receptor via aromatic interactions (Fig. 3b) and use phagocytosis to absorb particles larger than 0.5 μm, whereas honeycomb cells use endocytosis to internalize 5 μm of particles (Kuroiwa et al., 2023;Revel et al., 2018). The entry of microplastics into macrophages by phagocytosis induces a shift towards the glycolytic pathway and reduces respiration in mitochondria, thus macrophages cannot break down MPs (Merkley et al., 2022). ...

Tim4, a macrophage receptor for apoptotic cells, binds polystyrene microplastics via aromatic-aromatic interactions
  • Citing Article
  • March 2023

The Science of The Total Environment

... Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a newly discovered member of the TNF family (Jeremias et al., 1998;Kayagaki et al., 1999), is expressed in many normal tissues including the spleen, thymus, lung, prostate and on the surface of T cells, B cells, macrophages, and natural killer cells (Wang and El-Deiry, 2003;Dadey et al., 2021). Because its high tumor specificity compared to other TNF family members, recombinant TRAIL, TRAIL receptor agonists and other therapeutic agents had been studied for cancer therapies by activating TRAIL pathway to induce tumor-selective apoptosis (Singh et al., 2021;von Karstedt et al., 2017;Yuan et al., 2018). ...

Involvement of TNF-Related Apoptosis-Inducing Ligand in Human CD4+ T Cell-Mediated Cytotoxicity
  • Citing Article
  • March 1999

The Journal of Immunology

... CAR-T and CAR-NK cell therapies have shown promising clinical outcomes in the treatment of cancer, as exemplified by the FDA approval of CAR-T cell therapy for B cell malignancy 72,73 . Despite these breakthroughs, challenges such as metabolic disruption, cellular exhaustion, and trogocytosis remain, which limit their effectiveness in the tumor microenvironment [74][75][76][77][78] . ...

Shaping of T Cell Functions by Trogocytosis

Cells

... [122][123][124] Furthermore, MWCNTs enhance macrophage activation by upregulating CD40 and CD80, stimulating phagocytosis through NLRP3 inflammasome activation via Tim4 receptor recognition. 125,126 Collectively, these NPs contribute to sepsis treatment by modulating inflammatory pathways, enhancing pathogen clearance and maintaining inflammatory balance. Table 2 provides a detailed classification and mechanism overview of macrophage-targeted nanoparticles in sepsis research, highlighting various NP types and their specific roles in modulating macrophage functions. ...

Tim4 recognizes carbon nanotubes and mediates phagocytosis leading to granuloma formation

Cell Reports

... Phagocytosis is an important cellular mechanism conserved in all multicellular organisms from protozoans to mammals, including humans (Boulais et al., 2010;Gordon, 2016). Macrophages phagocytose endogenous material, like apoptotic cells (Fadok et al., 1998;Liu et al., 2006;Erwig and Henson, 2008;Kono and Rock, 2008;Suzanne and Steller, 2013;Kourtzelis et al., 2020) and cell debris, or foreign objects, such as pathogens (Chen et al., 2007;Gluschko et al., 2018) and toxic substances, like asbestos or silica particles (Murray and Wynn, 2011b;Nakayama, 2018). ...

Macrophage Recognition of Crystals and Nanoparticles

... After 60 min, the cellular uptake of LinearPMB10k-Rho increased, whereas that of 4arm-PMB10k-Rho plateaued, which indicates that the rate of cellular uptake of 4armPMB10k-Rho was balanced by the rate of diffusion to the outside of the cells. Rhodamine B-labeled PMB polymers have been reported to localize in the mitochondria because the rhodamine unit has an affinity for these organelles [33]. Thus, LinearPMB10k-Rho could have a stronger affinity We quantitatively investigated the cellular uptake of the polymers using flow cytometry. ...

Fast and effective mitochondrial delivery of ω-Rhodamine-B-polysulfobetaine-PEG copolymers

... A recent study indicated that TIM-3 loss on DCs reduced tumor burden in non-small-cell lung carcinoma model 64 . Conversely, TIM-3 monoclonal antibodies increased the inflammation severity in a Th1mediated EAE model and a bleomycin-induced pulmonary fibrosis model 69,70 . Considering the differential actions of TIM-3 in specific cell types and in different contexts, therapeutic approaches targeting TIM-3 should be carefully developed with consideration of its characteristics in specific disease conditions. ...

Cutting Edge: Anti–TIM-3 Treatment Exacerbates Pulmonary Inflammation and Fibrosis in Mice
  • Citing Article
  • October 2017

The Journal of Immunology

... Agro-nanotechnology is a promising strategy that uses different nanomaterials for solving problems related to the agriculture and food sectors [4]. Silicon dioxide (SiO 2 ) and titanium dioxide (TiO 2 ) nanoparticles (NPs) are two of the most investigated nanomaterials due to their high chemical and thermal stability, low toxicity, low production cost, and easy surface functionalization [5,6]. Therefore, in recent years, different nanomaterials derived from SiO 2 and TiO 2 , including SiO 2 -TiO 2 composites, have been synthesized [7,8]. ...

SiO2 and TiO2 nanoparticles synergistically trigger macrophage inflammatory responses

Particle and Fibre Toxicology

... Other studies showed that gene mutations are involved (23). Cytotoxic T cells and IFN-γ induce cancer cells to acquire genetic instability (24). If ICI treatment increases the TMB, β-catenin may be involved in mechanisms of acquired resistance to ICIs. ...

IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting